Agilon Health

AGL

ATLANTA, GA – – (Globe Newswire – January 8, 2024) – – Holzer & Holzer, LLC is investigating whether Agilon Health, Inc. (“Agilon Health” or the “Company”) (NYSE: AGL) complied with federal securities laws.  On January 5, 2024, Agilon Health announced revised guidance expectations for 2023 and stated that “[d]uring 2023, agilon health experienced an increase in medical expenses attributable to higher-than-expected specialist visits, Part B drugs, outpatient surgeries, and supplemental benefits, partially offset by lower hospital medical admissions.” Following this news, the price of the Company’s stock dropped.

If you purchased Agilon Health stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/agilon-health/ to discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information

Name(Required)
Address
Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
 
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share